Pankaj R Patel


pankajManaging Director & Chairman – The Cadila Healthcare

Born in 1951, Pankaj Ramanbhai Patel is the Managing Director and the current Chairman of the fifth largest pharmaceutical company in India, The Cadila Healthcare. Patel made it to the 26th place on Forbes magazine’s first annual list of the 40 richest Indians (2004) with an estimated net worth of $510 million. Pankaj Patel is a graduate from Gujarat University, and holds a degree as Bachelor of Pharmacy. He went on to pursue M.Pharma in Pharmaceutics & Pharmaceutical Technology from L. M. College of Pharmacy.He played an active role in fighting against swine flu, which was spreading at a fast pace in the recent past, by securing approval for his group, from the Drug Controller General of India to launch his VaxiFlu-s,the first Indian- made H1N1 vaccine- and one of only few such vaccines in the world.

Key attributes:

1. Today, Pankaj enjoys 75% stake in listed flagship Cadila Health care and makes branded and generic drugs and rabies vaccines.

2. Cadila and Eli Lilly together under a vision instigated by Patel, They are developing a cardiovascular drug, which could help the Indian company to earn $300 million in milestone payments and royalties.

3. His company is an employer to 12,000 people worldwide.

FacebookGoogle+TwitterWhatsApp